Fotocitizen / Pixabay

Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency

• Post author:Jessica Lynn
• Post published:February 6, 2024
• Post category:Growth hormone deficiency/Pediatric Growth Hormone Deficiency (GHD)

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency

source: pixabay.com

Sogroya Now Approved for Pediatric Growth Hormone Deficiency (GHD)

• Post author:Jessica Lynn
• Post published:May 3, 2023
• Post category:Pediatric Growth Hormone Deficiency (GHD)

  In July 2022, Patient Worthy reported on data from the Phase 3 REAL 4 clinical trial. During the trial, researchers compared the safety, efficacy, and tolerability of Sogroya (somapacitan-beco)…

Continue Reading Sogroya Now Approved for Pediatric Growth Hormone Deficiency (GHD)

source: unsplash.com

ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency

• Post author:Jessica Lynn
• Post published:July 6, 2022
• Post category:Growth hormone deficiency/Pediatric Growth Hormone Deficiency (GHD)

  The ENDO 2022 Annual Congress took place from June 11-14, 2022. During the Congress, stakeholders met to discuss care, treatments, and research within endocrinology. In a news release from…

Continue Reading ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency

https://pixabay.com/en/denied-insurance-rejected-stamp-1936877/

FDA Rejects Growth Hormone Deficiency Drug

• Post author:Kendall Mason
• Post published:February 16, 2022
• Post category:Pediatric Growth Hormone Deficiency (GHD)

Despite undergoing clinical development, many drugs never receive approval from the FDA. Recently, this happened to a treatment for growth hormone deficiency (GHD). The medication, titled somatrogon and owned by…

Continue Reading FDA Rejects Growth Hormone Deficiency Drug

source: pixabay.com

Ways to Support Those with Pediatric Growth Hormone Deficiency

• Post author:Trudy Horsting
• Post published:April 28, 2021
• Post category:Growth hormone deficiency/Pediatric Growth Hormone Deficiency (GHD)

Growth hormone deficiency (GHD) influences patients both physically and mentally. The condition means patients' bodies don't produce enough growth hormone. As a result, they don't develop the same way as…

Continue Reading Ways to Support Those with Pediatric Growth Hormone Deficiency

Phase 3 Trial for Pediatric Growth Hormone Deficiency in China Completed Enrollment On Time Despite COVID-19 Setback

• Post author:Trudy Horsting
• Post published:April 27, 2021
• Post category:Pediatric Growth Hormone Deficiency (GHD)

VISEN Pharmaceuticals has recently announced that enrollment has been completed for their Phase 3 clinical trial examining the safety and efficacy of TransCon hGH compared to daily rhGH in patients…

Continue Reading Phase 3 Trial for Pediatric Growth Hormone Deficiency in China Completed Enrollment On Time Despite COVID-19 Setback